The core activity of LifeDX SA is the development and manufacture of rapid diagnostic tests and devices for healthcare, particularly for the early detection and diagnosis of diseases such as HIV, syphilis, hepatitis, COVID-19, influenza, and malaria. The company focuses on creating accessible and cost-effective solutions for healthcare in developing and middle-income countries.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered4
Rapid Diagnostic Tests (RDTs)
Rapid, user-friendly paper-based diagnostics for detecting specific analytes in liquid samples, including COVID-19, influenza, RSV, streptococcal, HIV, hepatitis, syphilis, malaria, food safety and biomarker tests.
ELISA Kits
Plate-based immunoassay kits for qualitative and quantitative detection of respiratory, viral hepatitis, brain damage and sexually transmitted infection markers, including SARS-CoV-2, measles, HCV, HBsAg, NR-2 and syphilis assays.
Next Generation Sequencing (NGS) Solutions
NGS-based diagnostic solutions with sample preparation kits, bioinformatics algorithms and result-visualization software for HIV drug resistance and embryo aneuploidy screening in IVF.
Technologies and Projects in development
Development of microfluidic chips with electrochemical biosensors and ELISA/LF projects for veterinary diagnostics and food safety tests, including antibiotics, growth stimulants and mycotoxins.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.